*恭喜浙江省农业科学院俞老师在SCI期刊 Environmental Science and Pollution Research(IF:2.914)上成功发表
*恭喜西安理工大学张老师,环境水利专业,文章成功发表在SCI期刊Environmental Science and Pollution Research上,IF2.914
*恭喜山东交通学院谢老师在SCI期刊APPLIED SURFACE SCIENCE(IF5.15)上成功发表
*恭喜华中科技大学黄老师在SCI期刊 ACS Applied Materials & Interfaces(IF8.456)上成功发表
*恭喜中南大学湘雅医院黄医生在Frontiers in Oncology(IF 4.137)上成功发表
*恭喜复旦大学辛博士在SCI期刊 FEBS LETTERS(IF2.675)上成功发表
*恭喜中南大学陈博士在THIN-WALLED STRUCTURESSCI期刊(IF3.488)上成功发表
*恭喜湖南工学院郭老师在SCI期刊SIMULATION MODELLING PRACTICE AND THEORY(IF2.42)上成功发表
*恭喜东华大学闫老师在SCI期刊Advanced Functional Materials(IF 15.621)上成功发表
*恭喜安徽医科大学肖老师在SCI期刊BMC CELL BIOLOGY(IF 3.485)上成功发表
*恭喜四川大学华西医院谢医生在SCI期刊European Heart Journal: Acute Cardiovascular Care(IF 3.734)上成功发表

0591-83301811

周一~周日, 8:00 - 23:00

13107667616

周一~周日, 8:00 - 23:00

service@editideas.cn

随时欢迎您的来信!

2021年最新SCI期刊影响因子查询系统

期刊名称:
ISSN:
期刊研究方向:
IF范围:
中科院分区:
SCI/SCIE:
是否OA期刊:
排列方式:

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 期刊详细信息

基本信息
期刊名称 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
期刊ISSN 0731-7085
期刊官方网站 http://www.elsevier.com/wps/find/journaldescription.cws_home/525434/description#description
是否OA
出版商 Elsevier
出版周期 Semimonthly
始发年份 1983
年文章数 726
最新影响因子 3.571(2021)
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 CHEMISTRY, ANALYTICAL 分析化学2区
PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.15 0.786 1.144
Chemistry
Spectroscopy
15 / 69 78%
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
28 / 115 76%
Chemistry
Analytical Chemistry
28 / 110 75%
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
32 / 164 80%
Pharmacology, Toxicology and Pharmaceutics
Drug Discovery
38 / 146 74%
补充信息
自引率 13.00%
H-index 114
SCI收录状况 Science Citation Index Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0731-7085%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/jpba/
收稿范围
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focussing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants. Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin. Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology.
In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.
收录体裁
Reviews
Full Length Research Papers
Short Communications
投稿指南 https://www.elsevier.com/journals/journal-of-pharmaceutical-and-biomedical-analysis/0731-7085/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/journal-of-pharmaceutical-and-biomedical-analysis/0731-7085/guide-for-authors
编辑信息
近期成功发表案例展示